Your browser doesn't support javascript.
loading
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
Haynes, Richard; Judge, Parminder K; Staplin, Natalie; Herrington, William G; Storey, Benjamin C; Bethel, Angelyn; Bowman, Louise; Brunskill, Nigel; Cockwell, Paul; Hill, Michael; Kalra, Philip A; McMurray, John J V; Taal, Maarten; Wheeler, David C; Landray, Martin J; Baigent, Colin.
Afiliación
  • Haynes R; Medical Research Council Population Health Research Unit (R.H., P.K.J., W.G.H., B.C.S., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Judge PK; Clinical Trial Service Unit (R.H., P.K.J., N.S., W.G.H., B.C.S., L.B., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Staplin N; Medical Research Council Population Health Research Unit (R.H., P.K.J., W.G.H., B.C.S., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Herrington WG; Clinical Trial Service Unit (R.H., P.K.J., N.S., W.G.H., B.C.S., L.B., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Storey BC; Clinical Trial Service Unit (R.H., P.K.J., N.S., W.G.H., B.C.S., L.B., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Bethel A; Medical Research Council Population Health Research Unit (R.H., P.K.J., W.G.H., B.C.S., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Bowman L; Clinical Trial Service Unit (R.H., P.K.J., N.S., W.G.H., B.C.S., L.B., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Brunskill N; Medical Research Council Population Health Research Unit (R.H., P.K.J., W.G.H., B.C.S., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Cockwell P; Clinical Trial Service Unit (R.H., P.K.J., N.S., W.G.H., B.C.S., L.B., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Hill M; Nuffield Department of Population Health, and Diabetes Trials Unit, Radcliffe Department of Medicine (A.B.), University of Oxford, UK.
  • Kalra PA; Clinical Trial Service Unit (R.H., P.K.J., N.S., W.G.H., B.C.S., L.B., M.H., M.J.L., C.B.), University of Oxford, UK.
  • McMurray JJV; Department of Infection, Immunity and Inflammation, University of Leicester, UK (N.B.).
  • Taal M; Department of Nephrology, University Hospitals Birmingham, UK (P.C.).
  • Wheeler DC; Medical Research Council Population Health Research Unit (R.H., P.K.J., W.G.H., B.C.S., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Landray MJ; Clinical Trial Service Unit (R.H., P.K.J., N.S., W.G.H., B.C.S., L.B., M.H., M.J.L., C.B.), University of Oxford, UK.
  • Baigent C; Department of Nephrology, Salford Royal Hospital NHS Foundation Trust, UK (P.A.K.).
Circulation ; 138(15): 1505-1514, 2018 10 09.
Article en En | MEDLINE | ID: mdl-30002098
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Volumen Sistólico / Tetrazoles / Función Ventricular Izquierda / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Insuficiencia Renal Crónica / Irbesartán / Tasa de Filtración Glomerular / Aminobutiratos / Insuficiencia Cardíaca / Riñón Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Circulation Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Volumen Sistólico / Tetrazoles / Función Ventricular Izquierda / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Insuficiencia Renal Crónica / Irbesartán / Tasa de Filtración Glomerular / Aminobutiratos / Insuficiencia Cardíaca / Riñón Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Circulation Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido